ISGEDR 2025 – Symposium on Genetic Eye Disease

At the International Society of Genetic Eye Disease and Retinoblastoma (ISGEDR) conference on Sept 11-13 in Oslo, leading experts will gather to present and discuss the latest advances in disease understanding and therapy development.

This year, three participants will focus on adaptive optics (AO) retinal imaging, a technology that can radically improve and accelerate research and clinical trials in inherited retinal diseases. Julie Van Puyvelde, Kiyoko Gocho and Nicolas Chateau will present clinical evidence of early phenotyping at the cellular level, as well as assessments of disease progression on extremely short timescales using rtx1 AO cameras.

If you plan to attend the ISGEDR conference and share our vision that therapy and imaging should advance together, don’t miss these presentations!

SESSION 6: IRD – Gene Therapy, Natural history & Outcome Measures

Friday Sept 12, 16:00-17:30, Auditorium I 

16:34 – Progression Assessment with OCT and Adaptive Optics: A Subset Analysis of the KEYS study. Kiyoko Gocho, 15-20 National Eye Hospital and Kobe Eye Center

 

Poster Session associated to Ophthalmic Genetics Session 3

Saturday Sept 13, 11:00-11:30, Auditorium I

#63 – Deep Retinal Phenotyping in a Case of Best Vitelliform Macular Dystrophy using Adaptive Optics Imaging. Julie Van Puyvelde, Ghent University Hospital

#65 – Imaging protocol for retinal phenotyping at the microscopic level in retinitis pigmentosa. Nicolas Chateau, Imagine Eyes, for the AO-Vision project

 

Learn more about ISGEDR 2025 here : https://lnkd.in/e6RD4wGz

Learn more about the rtx1 AO camera here.